If food-contact packaging was approved before 12 August 2026 and will now be placed on the EU market, buyers should recheck whether the existing PFAS approval still represents the current commercial packaging. The priority is not automatic retesting. It is to confirm the placement date, packaging revision, supplier-declaration scope, tested sample, commercial-lot equivalence, and any supplier, site, material, or formulation changes since the original approval. An older PFAS report can remain useful when its scope still matches current supply; if that link has been broken, the approval should be updated, reopened, or requalified before the next purchasing decision.

The EU Packaging and Packaging Waste Regulation (PPWR) now generally applies, and Article 5(5) applies PFAS concentration limits to food-contact packaging placed on the market from 12 August 2026.

Start With One Question: Does the Previous Approval Still Cover What You Buy Today?

A previous approval should not be treated as permanently attached to a packaging code.

The useful review chain is:

Previous Approval → Placement Date → Approved Packaging Revision → Existing PFAS Evidence → Current Commercial Revision → Supplier / Site / Material Changes → Evidence Still Representative? → Approval Decision

The last step can lead to five different outcomes:

This distinction prevents two opposite errors: repeating qualification work that existing evidence can still support, and continuing an approval after the evidence no longer represents the material being purchased.

Recheck the Placement Date Before Reviewing the Test File

The first recheck is commercial timing.

The European Commission's 2026 PPWR guidance states that food-contact packaging containing PFAS and produced before 12 August 2026 does not receive a general stock-exhaustion transition. Packaging placed on the market after that date must meet the applicable PFAS limits, while packaging already placed on the market before that date may remain there.

This means that an old manufacturing date does not, by itself, close the buyer's review.

For existing inventory, confirm:

• when the packaging was or will be placed on the EU market;
• which packaging revision the stock represents;
• whether its existing PFAS evidence covers that revision;
• whether the approval file was built for the same supply period and commercial configuration.

The practical question is no longer simply:

Was this packaging approved before August 2026?

It is:

Does the approval still support the packaging that is being placed on the market now?

Map the Old Approval to the Current Commercial Packaging

Before asking for another laboratory report, reconstruct what the original approval actually covered.

The record should connect:

Packaging Code → Revision → Substrate → Coating → Adhesive → Ink → Functional Layers → Manufacturing Source → Tested Sample → Approval Date

Then compare that chain with current commercial supply.

A document may be technically valid and still have little value for today's approval if it belongs to:

• an earlier packaging revision;
• an obsolete coating formulation;
• a different adhesive or ink system;
• another production site;
• a development sample;
• a raw material rather than the finished packaging under review.

For the broader PPWR relationship between packaging identity, supplier information, testing, technical documentation, production control, and traceability, the PPWR packaging documentation and supplier qualification framework should remain the upper-level reference.

The current page has a narrower task: determining whether an already-approved PFAS file still applies to today's commercial package.

Does the Existing PFAS Report Still Support the Approval?

Buyers do not need to rebuild the analytical methodology inside every approval review.

They do need to determine whether the existing report answers the regulatory decision now being relied on.

Article 5(5) contains separate concentration boundaries for individual targeted PFAS, summed targeted PFAS, and PFAS including polymeric PFAS. The important recheck here is whether the existing evidence addresses the relevant boundary and the correct commercial packaging—not to repeat the full analytical-method discussion.

If the current file does not make that clear, use the separate ChemicalCell analysis on how PFAS in food-contact packaging should be verified under the EU PPWR for targeted analysis, total fluorine, precursor-related analysis, polymeric PFAS, method fitness, reporting basis, and analytical limitations.

For the current approval, reduce the report review to four questions:

1. What physical material or package was tested?
2. Which packaging revision did that sample represent?
3. What PFAS decision can the report actually support?
4. Is that sample still representative of current commercial supply?

If one of those answers is unknown, the report should not automatically remain attached to the approval.

What Existing Documents Can—and Cannot—Support

The number of documents in the file is less important than whether each document remains connected to the current approval decision.

A Current COA Does Not Automatically Refresh an Old PFAS Approval

This distinction is especially important in routine procurement.

A conventional COA may control:

• basis weight;
• coating weight;
• viscosity;
• solids;
• moisture;
• colour;
• adhesion;
• other agreed release properties.

Those parameters can remain within specification even when a supplier changes a low-dose functional component, processing aid, upstream source, or production route.

A passing COA therefore answers:

Did this lot meet the agreed release specification?

It does not automatically answer:

Is the PFAS evidence used for the original approval still representative of this lot?

If PFAS-specific controls are included in an agreed specification and supported by an appropriate evidence system, they can contribute directly to approval. If they are absent, routine COA conformity and PFAS approval status should remain separate decisions.

Recheck Supplier Declarations Against the Exact Approved Version

Statements such as:

• “PFAS-free”;
• “no intentionally added PFAS”;
• “fluorine-free”;

should not be accepted without scope.

For previously approved packaging, a current supplier declaration should be matched to at least:

commercial grade + formulation revision + manufacturing source + market scope + effective period

This matters when the supplier has changed a formulation while retaining the same trade name.

A declaration prepared for Revision 04 cannot automatically be applied backward to Revision 03. An old declaration for Revision 03 should not automatically be applied forward after Revision 04 enters commercial supply.

The same problem can occur when:

• manufacturing moves to another site;
• a coating manufacturer changes an upstream component;
• an alternative raw-material source is introduced;
• a processing aid is replaced;
• an adhesive or ink formulation changes.

For product-level versioning and evidence control, ChemicalCell's PFAS product tracking and change-control framework addresses the wider data-governance task.

For the current buyer decision, the rule is narrower:

If the declaration cannot be assigned to the exact commercial version being purchased, the PFAS approval remains incomplete.

Recheck Development Evidence Before It Becomes Commercial Evidence

Existing approval files often contain reports generated early in a substitution or packaging-development project.

A passing development sample does not have the same approval value as a verified commercial lot.

Development Sample

Useful for answering:

Is this material route worth continuing?

The risk is that the sample may use laboratory coating conditions, provisional materials, different coat weight, or a formulation that later changes.

Pilot or Trial Production

Useful for determining whether the proposed construction survives real converting conditions.

The buyer should still confirm that the:

• substrate;
• coating;
• adhesive;
• ink;
• functional layers;
• production source;
• relevant process configuration

match the intended commercial package.

Commercial Production

This is where the approval file must connect to the material actually being purchased.

If the original PFAS approval was based on a development or trial structure and no record demonstrates equivalence to routine production, the correct outcome is usually:

Require Commercial-Lot Verification

rather than automatically maintaining approval.

The risk is evidence transfer: a valid result for Sample A becomes an approval for Commercial Package B without showing that A and B represent the same controlled construction.

Which Changes Should Reopen the PFAS Approval?

PPWR Article 15 requires manufacturers to maintain conformity in series production and to take relevant changes in packaging design, characteristics, harmonised standards, common specifications, or other technical specifications into account. Where necessary, reassessment is required.

For procurement and supplier qualification, this should become a risk-based change review.

The trigger should follow the effect of the change on the previous decision, rather than whether the supplier labels the change “minor” or “major.”

A Supplier Change Can Matter Even When the Main Material Specification Does Not Change

A packaging material can continue meeting conventional performance requirements while its PFAS evidence basis changes.

For example, a revised coating could remain within the same:

• solids specification;
• viscosity range;
• coat-weight target;
• adhesion requirement;
• grease-performance target.

If a component, processing aid, or upstream raw-material source changed, the buyer still needs to determine whether the previous PFAS evidence covers the revised formulation.

This is why specification comparison should include two separate layers:

Performance Equivalence

and

Evidence Equivalence

A second source that reproduces barrier performance has not completed qualification if its PFAS declaration, tested configuration, commercial source, or change-control terms remain unresolved.

When Can the Existing Approval Be Kept?

An old approval does not need to be reopened merely because the original test predates 12 August 2026.

Keeping the existing approval can be reasonable when the buyer can show continuity across the relevant evidence chain:

• the same commercial packaging identity;
• the same controlled revision;
• the same relevant material construction;
• the same manufacturing source, where source matters to the evidence;
• no unassessed composition-relevant change;
• existing PFAS evidence remains applicable to the current package;
• current supplier documentation covers the relevant supply period;
• series production remains equivalent to the approved configuration.

The key principle is:

Evidence age alone is not the decision. Evidence representativeness is.

A 2025 report tied to an unchanged and traceable commercial package may remain more useful than a 2026 report generated from an unmatched material or unclear packaging revision.

When Should the Buyer Request Updated Evidence?

Request updated documentation before reopening the full qualification when the packaging itself appears unchanged but the file contains an administrative or traceability gap.

Typical cases include:

• the declaration has no revision number;
• the supplier has issued a newer declaration but has not explained which lots it covers;
• the manufacturing source is missing;
• the effective period is undefined;
• the PFAS definition used in the statement is unclear;
• the analytical report can be matched to the package, but the supplier cannot confirm continued formulation equivalence.

The objective is to close the missing link.

It is not necessary to restart laboratory and application testing automatically when updated controlled records can demonstrate that the approved configuration remains unchanged.

When Should Qualification Be Reopened?

Reopen the approval when an identified change could invalidate the basis of the previous decision.

Typical triggers include:

• changed barrier coating chemistry;
• formulation revision affecting functional components or processing aids;
• site transfer with unresolved source equivalence;
• new upstream material source;
• different adhesive, ink, primer, or seal layer;
• unexplained discrepancy between current documentation and old analytical evidence;
• inability to identify which commercial package the original report represents.

At this stage, the buyer should define which decision has reopened.

A composition-document gap may require supplier evidence.

An analytical-evidence gap may require testing.

A commercial-representativeness gap may require a production sample.

A functional-material change may require both PFAS reassessment and application requalification.

This avoids repeating unrelated qualification work.

When Does a PFAS-Free Replacement Become a Separate Material-Selection Project?

Sometimes the recheck shows that the existing material can no longer be maintained and an alternative is required.

At that point, the page task changes.

Selecting a new PFAS-free coating involves performance variables such as grease resistance, substrate interaction, folding, heat sealing, coat weight, storage, and converting conditions. Those questions should be handled separately from the existing-approval review.

For paper and fibre applications, the PFAS-free barrier coating qualification guide covers that material-selection decision.

A replacement should then return to the current approval chain:

New Material → Sample → Performance Qualification → PFAS Evidence → Commercial Lot → Controlled Approval

This keeps regulatory evidence and application performance connected without treating them as the same test.

Final Decision Framework for Previously Approved Packaging

Before the next purchase order, review the existing approval through this sequence.

Keep Existing Approval

Use when:

• the current package is the same controlled commercial configuration;
• supplier evidence remains valid for the current revision and period;
• no composition-relevant change has occurred;
• existing PFAS evidence still supports the current decision.

Request Updated Evidence

Use when:

• the commercial package appears unchanged;
• evidence continuity is likely;
• a declaration, revision, source, effective period, or other traceability field is missing.

Reopen Qualification

Use when:

• formulation, functional component, site, source, or package construction has changed;
• the existing evidence cannot be assigned confidently to current supply;
• a previous approval conclusion may have been invalidated.

Require Commercial-Lot Verification

Use when:

• qualification relied on a development or pilot sample;
• scale-up introduced material or process changes;
• commercial supply was never reconciled with the tested configuration.

Start Second-Source Qualification

Use when:

• a new supplier or alternative material is being introduced;
• incumbent evidence cannot be transferred to the second source;
• both technical comparability and PFAS evidence must be established for the new commercial supply.

This five-outcome framework is more useful than a single “PFAS compliant / non-compliant” checkbox because it identifies the next purchasing action.

What Should Buyers Send in the Next Supplier Review or RFQ?

If the recheck identifies an unresolved material or supplier issue, the next request should contain enough information to connect a new response to the existing approval.

Useful inputs include:

• current packaging or component identity;
• exact material grade;
• existing specification;
• approved packaging revision;
• previous PFAS declaration or test report;
• supplier and manufacturing source;
• known formulation or source changes;
• required commercial application;
• intended EU food-contact use;
• sample or commercial-lot requirement;
• whether the request concerns continued approval, replacement, or second-source qualification.

Suppliers of packaging and packaging materials have PPWR information and documentation obligations that support the manufacturer's conformity assessment, while responsibility for the packaging conformity decision remains with the relevant economic operator under the Regulation.

Where the recheck reveals a material-level gap—such as an outdated supplier declaration, changed commercial grade, alternative raw-material source, replacement coating, sample requirement, or second-source project—buyers can use the ChemicalCell RFQ process to provide the current specification, existing evidence, target material, sample needs, and qualification requirements.

The RFQ should start from the unresolved decision identified during the recheck rather than requesting another generic “PFAS-free” certificate.